MedPath

Hyoscyamine Sulfate Extended-Release

Hyoscyamine Sulfate Extended-Release Tablets, 0.375 mg PI-9328

Approved
Approval ID

2bf8d44e-e1b2-4a1d-9914-00bb7ef1293e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 17, 2010

Manufacturers
FDA

Carilion Materials Management

DUNS: 079239644

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hyoscyamine Sulfate Extended-Release

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68151-5182
Product Classification
G
Generic Name
Hyoscyamine Sulfate Extended-Release
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 17, 2010
FDA Product Classification

INGREDIENTS (5)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYDROXYPROPYL CELLULOSE (TYPE H)Inactive
Code: RFW2ET671P
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
HYOSCYAMINE SULFATEActive
Quantity: 0.375 mg in 1 1
Code: F2R8V82B84
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Hyoscyamine Sulfate Extended-Release - FDA Drug Approval Details